This post was just published on ZYX Buy Change Alert.
Pluristem Therapeutics (PSTI) was bought at $4.16. It is trading at $6.59 as of this writing. This represents a gain of 58% in three trading days.
What To Do Now
Never look a gift horse in the mouth. You have two options.
- Take profits and exit the trade.
- Take profits on one-half of the position and continue to hold the remaining with a new stop zone of $5.18 to $5.23.
For tracking purposes, partial position will continue to be held.
Here is an excerpt from the original signal to buy this company with potential coronavirus cure:
Pluristem Therapeutics has announced preliminary data from its compassionate use program treating acute respiratory failure resulting from coronavirus. Seven patients were treated in three hospitals in Israel with Pluristem’s PLX cells. So far all seven patients are alive.
Trades posted on The Arora Report Market Blog have produced unrivalled performance since 2007. Please click here and scroll down to see the table of all trades. These trades have been scrutinized in real-time by thousands of investors across the globe. This provides easy verification of performance for newcomers to this site. Only those trades are included in the performance where the entry post was made available to subscribers to The Arora Report Market Blog. When the entry post is made available only to the paying subscribers and not posted in real-time on The Arora Report Market Blog, the resulting performance of the trade is not credited in the performance table. There are very nice gains on this trade but since the entry trade was not posted here for the free subscribers in real-time but only made available to the paying subscribers, handsome profits on this trade will not be added to the performance of The Arora Report Market Blog shown on the table.
A knowledgeable investor would have turned $100,000 into over $1,000,000 with the help from The Arora Report. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE TRIAL TO PAID SERVICES.